Tower Research Capital LLC (Trc) Celcuity Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Celcuity Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,680 shares of CELC stock, worth $21,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,680
Previous 1,873
10.3%
Holding current value
$21,050
Previous $30,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding CELC
# of Institutions
107Shares Held
30.3MCall Options Held
30.8KPut Options Held
152K-
Bvf Inc San Francisco, CA3.47MShares$43.4 Million1.64% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$29.6 Million0.92% of portfolio
-
Baker Bros. Advisors LP New York, NY1.87MShares$23.5 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$20.4 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.54MShares$19.2 Million0.4% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $187M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...